{
  "id": 11497,
  "label": "HSD10 mitochondrial disease",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0010327",
  "properties": {
    "xrefs": [
      "DOID:0060810",
      "GARD:0010716",
      "MEDGEN:781653",
      "MESH:C536080",
      "MESH:C564560",
      "OMIM:300220",
      "OMIM:300438",
      "Orphanet:391417",
      "SCTID:791000124107",
      "UMLS:C3266731"
    ],
    "synonyms": [
      "17-beta-hydroxysteroid dehydrogenase 10 deficiency",
      "17-beta-hydroxysteroid dehydrogenase X deficiency",
      "2-methyl-3-hydroxybutyric aciduria",
      "2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency",
      "3-hydroxyacyl-CoA dehydrogenase 2 deficiency",
      "HSD10 deficiency",
      "HSD10 mitochondrial disease",
      "HSD10 mitochondrial disease, X-linked dominant",
      "HSD10MD",
      "HSD17B10 deficiency",
      "MHBD deficiency",
      "MRXS10",
      "chorioathetosis with mental retardation and abnormal behavior",
      "chorioathetosis with mental retardation and abnormal behaviour",
      "mental retardation with chorioathetosis and abnormal behavior",
      "mental retardation with chorioathetosis and abnormal behaviour",
      "mental retardation, X-linked, syndromic 10",
      "mental retardation, X-linked, syndromic type 10",
      "HSD10 deficiency, atypical type",
      "X-linked intellectual disability-choreoathetosis-abnormal behavior syndrome",
      "X-linked intellectual disability-choreoathetosis-abnormal behaviour syndrome",
      "syndromic X-linked intellectual disability type 10",
      "17 beta-hydroxysteroid dehydrogenase type 10 deficiency",
      "2M3HBA",
      "3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency",
      "3H2MBD deficiency",
      "hydroxyacyl-CoA dehydrogenase II deficiency"
    ],
    "categories": [
      {
        "ref": "MONDO:0005071",
        "name": "nervous system disorder"
      }
    ],
    "definition": "A rare, life-threatening neurometabolic disease characterized by a progressive neurodegenerative course, epilepsy, retinopathy and progressive cardiomyopathy."
  },
  "isLeaf": false,
  "isRoot": false,
  "child_count": 3,
  "parents": [
    {
      "id": 5908,
      "label": "inborn mitochondrial metabolism disorder",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        16198,
        19107,
        23488
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "DOID:700",
          "GARD:0018887",
          "MEDGEN:1778113",
          "MESH:D028361",
          "NANDO:1200173",
          "NANDO:2100163",
          "Orphanet:68380",
          "UMLS:C1456275"
        ],
        "synonyms": [
          "mitochondrial disease",
          "mitochondrial genetic disorders",
          "mitochondrial metabolism disease"
        ],
        "definition": "Diseases caused by abnormal function of the mitochondria. They may be caused by mutations, acquired or inherited, in mitochondrial dna or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes."
      },
      "child_count": 42,
      "reference_id": "MONDO:0004069"
    },
    {
      "id": 24270,
      "label": "hereditary neurological disease",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        5714,
        6799
      ],
      "type_id": 0,
      "properties": {
        "synonyms": [
          "neurogenetic disease"
        ],
        "categories": [
          {
            "ref": "MONDO:0005071",
            "name": "nervous system disorder"
          }
        ],
        "definition": "A heterogeneous group of genetic conditions with Mendelian (autosomal dominant, recessive, or X-linked) or chromosomal etiology characterized by abnormalities in the brain, spinal cord, nerves, or muscles."
      },
      "child_count": 528,
      "reference_id": "MONDO:0100545"
    }
  ],
  "children": [
    {
      "id": 18417,
      "label": "HSD10 disease, infantile type",
      "isLeaf": true,
      "isRoot": false,
      "parents": [
        11497
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0017622",
          "MEDGEN:1843150",
          "Orphanet:391428",
          "UMLS:C5680025"
        ],
        "synonyms": [
          "2-methyl-3-hydroxybutyric aciduria, classic type",
          "2-methyl-3-hydroxybutyric aciduria, infantile type",
          "2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, classic type",
          "2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, infantile type",
          "HSD10 deficiency, classic type",
          "HSD10 deficiency, infantile type",
          "HSD10 disease, classic type",
          "MHBD deficiency, classic type",
          "MHBD deficiency, infantile type"
        ],
        "categories": [
          {
            "ref": "MONDO:0005071",
            "name": "nervous system disorder"
          }
        ],
        "definition": "HSD10 disease, infantile type is a clinical subtype of HSD10 disease, a rare neurometabolic disorder. It is characterized by normal early development until 6-18 months of life, followed by progressive neurodegeneration manifesting with developmental regression, progressive visual and hearing troubles, seizures, epilepsy, severe cardiomyopathy, lethargy, hypotonia, poor feeding, choreoathetosis, and movement disorders. Elevated blood levels of isoleucine metabolites and their excretion in urine are reported. The disease is usually fatal around 2-4 years of age."
      },
      "child_count": 0,
      "reference_id": "MONDO:0018322"
    },
    {
      "id": 18418,
      "label": "HSD10 disease, neonatal type",
      "isLeaf": true,
      "isRoot": false,
      "parents": [
        11497
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0017623",
          "MEDGEN:1842355",
          "Orphanet:391457",
          "UMLS:C5680026"
        ],
        "synonyms": [
          "2-methyl-3-hydroxybutyric aciduria, neonatal type",
          "2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, neonatal type",
          "HSD10 deficiency, neonatal type",
          "MHBD deficiency, neonatal type"
        ],
        "categories": [
          {
            "ref": "MONDO:0005071",
            "name": "nervous system disorder"
          }
        ],
        "definition": "HSD10 disease, neonatal type is the most severe form of HSD10 disease, a rare neurometabolic disorder. It is characterized by onset of severe metabolic/lactic acidosis, neurological and psychomotor delay, seizures and severe progressive hypertrophic cardiomyopathy in the neonatal period. Hepatic involvement and coagulopathy are rare. The disease is fatal within the first months of life."
      },
      "child_count": 0,
      "reference_id": "MONDO:0018323"
    },
    {
      "id": 22957,
      "label": "HSD10 disease, atypical type",
      "isLeaf": true,
      "isRoot": false,
      "parents": [
        11497
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0016749",
          "MEDGEN:1843277",
          "Orphanet:85295",
          "UMLS:C5680206"
        ],
        "synonyms": [
          "X-linked intellectual disability-choreoathetosis-abnormal behavior syndrome",
          "X-linked intellectual disability-choreoathetosis-abnormal behaviour syndrome",
          "HSD10 deficiency, atypical type",
          "Syndromic X-linked intellectual disability type 10"
        ],
        "categories": [
          {
            "ref": "MONDO:0005071",
            "name": "nervous system disorder"
          }
        ]
      },
      "child_count": 0,
      "reference_id": "MONDO:0037149"
    }
  ],
  "roots": [
    {
      "id": 5908,
      "label": "inborn mitochondrial metabolism disorder"
    },
    {
      "id": 24270,
      "label": "hereditary neurological disease"
    }
  ]
}